BeatO raises INR 11-75 Crore in pre-Series A round of funding
Category: #health  By Pankaj Singh  Date: 2019-03-22
  • share
  • Twitter
  • Facebook
  • LinkedIn

BeatO raises INR 11-75 Crore in pre-Series A round of funding
  • Apart from Orios Venture Partners, BeatO’s existing investors, Leo Capital & Blume Ventures also participated in the pre-Series A funding round.
  • The proceeds from the funding round would be utilized to further expand the company’s existing flagship glucometer product line and its retail & FMCG categories.

BeatO, a New Delhi-based health-technology startup, has reportedly announced the completion of a INR 11.75 crore pre-Series A funding round led by investor Orios Venture Partners (Orios VP).

Reports cite, apart from Orios VP, BeatO’s existing investors, Leo Capital & Blume Ventures also participated in the early-stage funding round. Proceeds from the funding round would be utilized to further expand the company’s existing flagship glucometer product line and would also go into its retail & FMCG categories.

According to a report by India FMCG News, the company would also be allocating a significant portion of the raised capital to its dedicated research & development R&D division, for upgradation of platform for auto-suggestions based readings of blood-sugar as well as for expediting product development.

The Managing Partner of Orios Venture Partners, Anup Jain stated that the diabetic population across the nation has reached 80 million and is further growing at a CAGR of more than 6%. BeatO facilitates the one platform where diabetes can be effectively managed & monitored by the user & caregivers in an extremely convenient manner.

The Chief Executive Officer of BeatO, Gautam Chopra stated that the growing disposable income across the Indian middle-class would increasingly lead to more discretionary spending in coming years. Chopra added, for a diabetic person, the company expects this income to be channeled into an increased consumption of different customized food & retail products as well as personalized management solutions.

According to reports, the exact amount invested by Orios Venture Partners into BeatO during the funding round has not been disclosed yet.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Acadia announces positive results of Phase 3 trial to treat psychosis
Acadia announces positive results of Phase 3 trial to treat psychosis
By Pankaj Singh

Acadia Pharmaceuticals, a renowned US-based biopharmaceutical company dedicated to the development of treatments for central nervous system disorders, reportedly announced positive outcomes from its Phase 3 HARMONY stu...

Senseonics’ Eversense® obtains non-adjunctive labeling claim in U.S.
Senseonics’ Eversense® obtains non-adjunctive labeling claim in U.S.
By Pankaj Singh

Senseonics Holdings, Inc., a US-based medical device startup company recently announced that users of its Eversense CGM (continuous glucose monitoring) system can now use the new Eversense CGM mobile application f...

Astellas Pharma inks a $3 Bln deal to acquire Audentes Therapeutics
Astellas Pharma inks a $3 Bln deal to acquire Audentes Therapeutics
By Pankaj Singh

Japanese pharmaceutical company, Astellas Pharma Inc. has reportedly entered into a definitive agreement to acquire biotech firm Audentes Therapeutics, Inc. at a price of US$60.00 per share in cash, representing equity...